Friday 21 July 2017

Neopharma invests $237m towards diabetes management in GCC

Neopharma, a leading pharmaceutical manufacturing company, has invested a total of BD90 million ($237 million) in a state-of-the-art Japanese factory that will manufacture supplements for patients in the pre-diabetic stage and also Type II diabe


Merck Serono, Neopharma in medicines deal

  Germany's Merck Serono said it would team up with an Abu Dhabi firm to produce medicines for the domestic and regional markets, the first multinational of its kind to make branded products in the UAE.  


Neopharma expands into new areas

Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, today announced plans to enter into biotechnology and nanotechnology-based research and manufacturing capabilities. The announcement came at a press conference held concurrently


UAE firm wins approval for H1N1 drug

Neopharma, a pharmaceuticals manufacturer based in Abu Dhabi, said it has received clearance from the UAE Ministry of Health for its antiviral medication Oseltamivir BR Flu. The Oseltamivir BR Flu is the outcome of a joint ventur

 1 2 3 4 5 >  Last ›

calendarCalendar of Events